siemens.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht
Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. Life Science Solutions from Siemens: Leading the Way in Science. Learn More Today!
- Security for your lab
Free Whitepaper Download
Protect Critical Environments
- Scale up production
Smart life science technologies
can optimize your project timelines
- A green lab approach
A Green Lab balances temp, humidity
& lighting for occupants' safety.
- Journey along a smart lab
Linking operational efficiency &
worker safety to stay ahead.
- Security for your lab
Suchergebnisse
Suchergebnisse:
Vor 7 Stunden · Mit dem Anstieg auf 788,70 EUR hat die Eli Lilly-Aktie (ISIN US5324571083) am 07.06.2024 ein neues All-Time-High erreicht und damit den Kurs vom 06.06.2024 eingestellt.
Vor 7 Stunden · CStone gibt bekannt, dass das CHMP der Europäischen Arzneimittelagentur die Zulassung von Cejemly® (Sugemalimab, Anti-PD-L1) als Erstlinientherapie für NSCLC empfiehlt | finanzen.net
Vor 2 Stunden · Recent updates in healthcare include the FDA expanding GSK's RSV vaccine to adults aged 50-59, the first approval for Geron's blood disorder drug Rytelo, and Pfizer's Paxlovid failing as a long COVID treatment. Additionally, the CDC reported a Texas bird flu strain lethal to ferrets, and Eli Lilly's Alzheimer's drug showing no major concerns.
Vor einem Tag · Lilly Endowment was established in 1937 by the founders of Eli Lilly & Co with gifts of stock in the pharmaceutical company. Over the years, it has become one of the largest private philanthropic foundations in the United States, using its resources to support various charitable causes. Despite the recent sales, the Endowment remains one of the largest shareholders in Eli Lilly & Co.
Vor 2 Stunden · Target Audience and Goal Statement. This activity is intended for hematology/oncology specialists and other members of the oncology multidisciplinary team (excluding the UK). The goal of this activity is for learners to be better able to select, sequence, and manage therapy for R/R CLL and R/R MCL using evidence-based management strategies.
Vor 7 Stunden · The costs associated with absenteeism and presenteeism (where a nurse may be at work, yet is unable perform at their highest capacity), including decreased productivity, often far exceed the direct medical and pharmaceutical costs. Other costs include reassignment and retraining of harmed staff who are unable to continue in their current positions, recruitment, orientation, and onboarding ...
Vor 7 Stunden · Opportunities in the market include collaborations between pharmaceutical companies for developing innovative therapies, increasing investments in research and development activities, and the adoption of personalized medicine approaches for treating bone cancer patients. Overall, the future growth prospects for the Bone Cancer Treatment market are positive, but industry players will need to ...
